Cargando…
生物材料增效NK细胞免疫疗法研究进展
NK cell immunotherapy is a promising antitumor therapeutic modality after the development of T cell immunotherapy. Structural modification of NK cells with biomaterials may provide a precise, efficient, and low-cost strategy to enhance NK cell immunotherapy. The biomaterial modification of NK cells...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
《浙江大学学报》编辑部
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409897/ https://www.ncbi.nlm.nih.gov/pubmed/37476938 http://dx.doi.org/10.3724/zdxbyxb-2022-0728 |
_version_ | 1785086343032864768 |
---|---|
collection | PubMed |
description | NK cell immunotherapy is a promising antitumor therapeutic modality after the development of T cell immunotherapy. Structural modification of NK cells with biomaterials may provide a precise, efficient, and low-cost strategy to enhance NK cell immunotherapy. The biomaterial modification of NK cells can be divided into two strategies: surface engineering with biomaterials and intracellular modification. The surface engineering strategies include hydrophobic interaction of lipids, receptor-ligand interaction between membrane proteins, covalent binding to amino acid residues, click reaction and electrostatic interaction. The intracellular modification strategies are based on manipulation by nanotechnology using membranous materials from various sources of NK cells (such as exosome, vesicle and cytomembranes). Finally, the biomaterials-based strategies regulate the recruitment, recognition and cytotoxicity of NK cells in the solid tumor site in situ to boost the activity of NK cells in the tumor. This article reviews the recent research progress in enhancing NK cell therapy based on biomaterial modification, to provide a reference for further researches on engineering NK cell therapy with biomaterials. |
format | Online Article Text |
id | pubmed-10409897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | 《浙江大学学报》编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-104098972023-08-10 生物材料增效NK细胞免疫疗法研究进展 Zhejiang Da Xue Xue Bao Yi Xue Ban Research Article NK cell immunotherapy is a promising antitumor therapeutic modality after the development of T cell immunotherapy. Structural modification of NK cells with biomaterials may provide a precise, efficient, and low-cost strategy to enhance NK cell immunotherapy. The biomaterial modification of NK cells can be divided into two strategies: surface engineering with biomaterials and intracellular modification. The surface engineering strategies include hydrophobic interaction of lipids, receptor-ligand interaction between membrane proteins, covalent binding to amino acid residues, click reaction and electrostatic interaction. The intracellular modification strategies are based on manipulation by nanotechnology using membranous materials from various sources of NK cells (such as exosome, vesicle and cytomembranes). Finally, the biomaterials-based strategies regulate the recruitment, recognition and cytotoxicity of NK cells in the solid tumor site in situ to boost the activity of NK cells in the tumor. This article reviews the recent research progress in enhancing NK cell therapy based on biomaterial modification, to provide a reference for further researches on engineering NK cell therapy with biomaterials. 《浙江大学学报》编辑部 2023-06-25 /pmc/articles/PMC10409897/ /pubmed/37476938 http://dx.doi.org/10.3724/zdxbyxb-2022-0728 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Research Article 生物材料增效NK细胞免疫疗法研究进展 |
title | 生物材料增效NK细胞免疫疗法研究进展 |
title_full | 生物材料增效NK细胞免疫疗法研究进展 |
title_fullStr | 生物材料增效NK细胞免疫疗法研究进展 |
title_full_unstemmed | 生物材料增效NK细胞免疫疗法研究进展 |
title_short | 生物材料增效NK细胞免疫疗法研究进展 |
title_sort | 生物材料增效nk细胞免疫疗法研究进展 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409897/ https://www.ncbi.nlm.nih.gov/pubmed/37476938 http://dx.doi.org/10.3724/zdxbyxb-2022-0728 |
work_keys_str_mv | AT shēngwùcáiliàozēngxiàonkxìbāomiǎnyìliáofǎyánjiūjìnzhǎn AT shēngwùcáiliàozēngxiàonkxìbāomiǎnyìliáofǎyánjiūjìnzhǎn |